The Screening of Renoprotective Agents by 99mTc-DMSA: A Review of Preclinical Studies.
CONCLUSION: In this review, the recent findings about the renoprotective agents were evaluated and screened with respect to the use of 99mTc-DMSA , which is preclinically and clinically used for animal cases and cancer patients under the treatment by radiotherapy and chemotherapy.
PMID: 31612808 [PubMed - in process]
Source: Current Radiopharmaceuticals - Category: Radiology Tags: Curr Radiopharm Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Radiology | Study | Toxicology | Urology & Nephrology